Is IPSC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IPSC. It does not provide personalized investment advice.

IPSC (Century Therapeutics, Inc. Common Stock) Stock Analysis - Financials

Century Therapeutics, Inc. Common Stock (IPSC) is a publicly traded Healthcare sector company. As of August 12, 2026, IPSC trades at $2.06 with a market cap of $357.10M and a P/E ratio of -14.54. IPSC moved -0.24% today. Year to date, IPSC is +107.08%; over the trailing twelve months it is +320.75%. Its 52-week range spans $0.34 to $3.04. Analyst consensus is strong buy with an average price target of $5.67. Rallies surfaces IPSC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are IPSC's key financials?

IPSC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IPSC recently traded at $2.06. Market cap is $357.10M. P/E ratio is -14.54. Revenue is $109.16M.

IPSC Key Metrics

Key financial metrics for IPSC
Metric	Value
Price	$2.06
Market Cap	$357.10M
P/E Ratio	-14.54
EPS	$-0.14
Dividend Yield	0.00%
52-Week High	$3.04
52-Week Low	$0.34
Volume	359
Avg Volume	0
Revenue (TTM)	$109.16M
Net Income	$-9.58M
Gross Margin	0.00%

IPSC Analyst Consensus

4 analysts cover IPSC: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.67.

Common questions about IPSC

What are IPSC's key financials?: IPSC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IPSC recently traded at $2.06. Market cap is $357.10M. P/E ratio is -14.54. Revenue is $109.16M.
Is IPSC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IPSC. It does not provide personalized investment advice.